Sangamo Therapeutics
SGMO
#10572
Rank
ยฃ23.22 M
Marketcap
ยฃ0.05606
Share price
0.00%
Change (1 day)
-82.01%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2026 (TTM): -ยฃ0.28

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ0.29. In 2025 the company made an earnings per share (EPS) of -ยฃ0.33 an increase over its 2024 EPS that were of -ยฃ0.39.

EPS history for Sangamo Therapeutics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.28-15.35%
2025-ยฃ0.33-13.73%
2024-ยฃ0.39
2022-ยฃ0.950.81%
2021-ยฃ0.9433.33%
2020-ยฃ0.706.9%
2019-ยฃ0.6622.54%
2018-ยฃ0.541.43%
2017-ยฃ0.53-31.37%
2016-ยฃ0.7775.86%
2015-ยฃ0.4448.72%
2014-ยฃ0.30-17.02%
2013-ยฃ0.369.3%
2012-ยฃ0.33-39.44%
2011-ยฃ0.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.06-1,857.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ13.17-4,673.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.79-721.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ0.96 234.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-ยฃ2.35 715.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ0.75-361.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ15.01-5,313.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-ยฃ0.06819-76.32%๐Ÿ‡บ๐Ÿ‡ธ USA